The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)pyrazolo[1,5-b]pyridazine-3-carboxamide
ID: ALA1078737
PubChem CID: 46882705
Max Phase: Preclinical
Molecular Formula: C13H9ClN4O
Molecular Weight: 272.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1cnn2ncccc12
Standard InChI: InChI=1S/C13H9ClN4O/c14-10-4-1-2-5-11(10)17-13(19)9-8-16-18-12(9)6-3-7-15-18/h1-8H,(H,17,19)
Standard InChI Key: UIFOBXKVALICCQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
13.3580 -14.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3568 -14.9994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0717 -15.4122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0699 -13.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7853 -14.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7902 -14.9948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5778 -15.2456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0597 -14.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5699 -13.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5870 -13.0853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3088 -12.6858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8800 -12.6598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8950 -11.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6216 -11.4387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6369 -10.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9317 -10.1955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2051 -10.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1933 -11.4150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4727 -11.8168 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 2 0
4 1 2 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 2 0
17 18 2 0
18 13 1 0
8 9 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.70 | Molecular Weight (Monoisotopic): 272.0465 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 59.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.69 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -2.03 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |